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Abstract
Background: The 2016 Dar Es Salaam Call to Action on Diabetes and Other non-
communicable diseases (NCDs) advocates national multi-sectoral NCD strategies and ac-
tion plans based on available data and information from countries of sub-Saharan Africa
and beyond. We estimated trends from 1980 to 2014 in age-standardized mean body
mass index (BMI) and diabetes prevalence in these countries, in order to assess the co-
progression and assist policy formulation.
Methods: We pooled data from African and worldwide population-based studies which
measured height, weight and biomarkers to assess diabetes status in adults aged18
years. A Bayesian hierarchical model was used to estimate trends by sex for 200 coun-
tries and territories including 53 countries across five African regions (central, eastern,
northern, southern and western), in mean BMI and diabetes prevalence (defined as either
fasting plasma glucose of  7.0mmol/l, history of diabetes diagnosis, or use of insulin or
oral glucose control agents).
Results: African data came from 245 population-based surveys (1.2 million participants)
for BMI and 76 surveys (182 000 participants) for diabetes prevalence estimates.
Countries with the highest number of data sources for BMI were South Africa (n¼17),
Nigeria (n¼ 15) and Egypt (n¼13); and for diabetes estimates, Tanzania (n¼8), Tunisia
(n¼7), and Cameroon, Egypt and South Africa (all n¼ 6). The age-standardized mean
BMI increased from 21.0 kg/m2 (95% credible interval: 20.3–21.7) to 23.0 kg/m2 (22.7–23.3)
in men, and from 21.9 kg/m2 (21.3–22.5) to 24.9 kg/m2 (24.6–25.1) in women. The age-
standardized prevalence of diabetes increased from 3.4% (1.5–6.3) to 8.5% (6.5–10.8) in
men, and from 4.1% (2.0–7.5) to 8.9% (6.9–11.2) in women. Estimates in northern and
southern regions were mostly higher than the global average; those in central, eastern
and western regions were lower than global averages. A positive association (correlation
coefficient ’ 0.9) was observed between mean BMI and diabetes prevalence in both
sexes in 1980 and 2014.
Conclusions: These estimates, based on limited data sources, confirm the rapidly
increasing burden of diabetes in Africa. This rise is being driven, at least in part, by
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increasing adiposity, with regional variations in observed trends. African countries’ ef-
forts to prevent and control diabetes and obesity should integrate the setting up of reli-
able monitoring systems, consistent with the World Health Organization’s Global
Monitoring System Framework.
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Introduction
Despite a high burden of infectious diseases in Africa, non-
communicable diseases (NCDs), including type 2 diabetes
mellitus (hereafter referred to as ‘diabetes’), are rising
steadily, contributing substantially to morbidity and mor-
tality. This is partly driven by a growing proportion of eld-
erly people.1 Furthermore, economic growth and
accompanying rapid urbanization have led to a burgeoning
wealthier middle class, possibly with shifts in diet and
physical activity contributing to the development of obes-
ity. This, with a genetic predisposition and epigenetic
changes,2,3 increases the risk of diabetes.4
Healthcare systems in Africa are now facing new dis-
ease burdens they are ill-equipped to manage. A number of
NCD initiatives informed by global resolutions, including
disease-specific initiatives such as for diabetes in Africa,5–8
have been developed.4,9 However, tangible responses from
national and international stakeholders have been slow,
and have largely overlooked adiposity and the unhealthy
food environment. Driven by maternal, newborn and child
health (MNCH), the traditional focus of investment in pre-
ventive health has been on undernutrition and food
insecurity.
To highlight the increasing diabetes prevalence and the
key contributory role played by obesity requires local data.
Furthermore, despite the strong link between adiposity and
diabetes, efforts to co-examine the burden of the two con-
ditions have been limited. Here, we estimate trends in age-
standardized mean body mass index (BMI) and diabetes
prevalence across Africa from 1980 to 2014. We aimed to
understand (i) the extent and quality of available data, (ii)
differences in patterns by regions and sex and (iii) the asso-
ciation of adiposity with diabetes prevalence.
Methods
The full methods of data collection, processing and ana-
lysis in the NCD Risk Factor Collaboration are available
elsewhere10,11 and in the Supplementary Textbox 1 (avail-
able as Supplementary data at IJE online). We estimated
trends for mean BMI and diabetes prevalence from 1980 to
2014, in 18-year-old adults across 53 countries organized
into five regions (Supplementary Table 1, available as
Supplementary data at IJE online).
We included data sources representative of national,
sub-national or community populations, with measured
weight and height or at least one of the following bio-
markers: fasting plasma glucose (FPG), oral glucose toler-
ance test (OGTT) or glycosylated haemoglobin (HbA1c).
We converted diabetes measured using different bio-
markers and definitions to a common definition of
FPG 7.0 mmol/l or a history of diabetes with ongoing
Key Messages
• This is the first detailed analysis of trends in adiposity and diabetes prevalence in Africa, both overall and by major
geographical regions.
• We used validated methods to re-analyse and pool population-based sources with measured data on at least one dia-
betes biomarker and/or body weight and height, including over 250 African sources.
• Age-standardized mean body mass index and diabetes prevalence have steadily increased across Africa since 1980,
tracking in general with the global averages.
• At any given time, estimates in northern Africa (driven by Egypt) and in southern Africa (driven by South Africa) ap-
peared higher than the global average, whereas estimates for other regions were mostly lower.
• There was a weak association between change in gross domestic product and change in adiposity and diabetes
prevalence, highlighting the coping challenges facing African countries, and the need for innovative approaches to
diabetes and obesity prevention and control.
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treatment, as described previously.11 Analyses were done
separately for men and women, using a statistical model
described and validated previously.10,11 The model had a
hierarchical structure in which estimates for each country
and year were informed by its own data, data from other
years in the same country and data in other countries in
the same region. The model also accounted for non-linear
time trends and age associations. The reported credible
intervals (CrIs) represent the 2.5th-97.5th percentiles of
the posterior distributions. Estimates were standardized
to the World Health Organization (WHO) standard
population.
Results
Data available
The analysis used data from 245 population-based surveys
encompassing 1.2 million participants aged 18 years for
BMI estimates, and 76 surveys (182 000 participants) for
diabetes estimates.10,11 These data were collected between
1984 and 2014 in 50 countries (94% of African countries)
for BMI, and between 1981 and 2014 in 32 countries
(60% of African countries) for diabetes (Figure 1).10,11
The distribution of surveys per region for BMI estimates
was as follows: 19 surveys (55 000 participants) for central
Africa, 68 (325 000) for eastern, 26 (170 000) for northern,
36 (299 000) for southern and 96 (394 000) for western
Africa (Figure 1a). South Africa (n¼ 17), Nigeria (n¼ 15)
and Egypt (n¼ 13) had the highest number of data points
(regardless of sources), whereas Angola, Djibouti and
Somalia had none (Figure 2).
Equivalent figures for diabetes estimates were one sur-
vey (3600 participants) for central Africa, 24 (77 000) for
eastern, 20 (43 000) for northern, 10 (14 000) for southern
and 21 (45 000) for western Africa (Figure 1b). Tanzania
(n¼ 8), Tunisia (n¼ 7), and Cameroon, Egypt and South
Africa (all n¼ 6) had the highest number of data points.
No data were available from 21 countries: Angola,
Burundi, Chad, Congo, Cote d’Ivoire, Djibouti, DR
Congo, Equatorial Guinea, Ethiopia, Gabon, Guinea
Bissau, Kenya, Madagascar, Mali, Mozambique, Namibia,
Niger, Sao Tome and Principe, Senegal, Sierra Leone,
Somalia (Figure 2).
Regarding the representativeness of data sources, 173
surveys (1.1 million participants) for BMI and 32 surveys
(104 000 participants) for diabetes prevalence estimates
had national coverage, whereas the remainder were sub-
national or community-based (Figure 1); 76 data sources
(203 000 participants) for BMI and 28 data sources
(60 000 participants) for diabetes (Figure 1) were collected
prior to 2000. These data were augmented with
Figure 1. Number of data sources available for body mass index and diabetes by African region and year.
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Figure 2. Number of data sources available for body mass index and diabetes by country in Africa.
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1453 sources for BMI and 675 for diabetes from other re-
gions. This helped the fitting of features, such as age pat-
terns and the effects of covariates through the hierarchical
structure, which also influenced trends.
Obesity trends
From 1980 to 2014, the age-standardized mean BMI
increased from 21.0 kg/m2 (95% CrI 20.3–21.7) to
23.0 kg/m2 (22.7–23.3) in men, and from 21.9 kg/m2
(21.3–22.5) to 24.9 kg/m2 (24.6–25.1) in women. Mean
BMI increased over time across all regions, paralleling the
global average; however there were suggestions, over re-
cent years, of steeper curves in women compared with
worldwide trends (Figure 3a). In both men and women,
the lowest mean BMI, over time, was usually recorded in
central Africa; whereas the highest, for men, was recorded
in northern Africa, and, for women, in northern and south-
ern Africa.
Mean BMI was higher than the global average in north-
ern and southern Africa, and lower in central, eastern and
western Africa. In many cases, CrIs around mean estimates
overlapped across regions and with that for the global
mean, due to a combination of limited available data and
the similarity of the estimates. A scatterplot of mean BMI
in men versus women in 2014 is shown in Figure 4. Across
the five regions, mean BMI appeared to be mostly higher in
women than in men. Per country, mean BMI in 2014
Figure 3. Trends in age-standardized mean body mass index and age-standardized diabetes prevalence by sex and region in Africa.
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ranged from 20.1 kg/m2 (19.2–21.0) in Ethiopia to
27.3 kg/m2 (26.5–28.1) in Egypt in men, and from
21.0 kg/m2 in Eritrea, Ethiopia and Madagascar to
30.6 kg/m2 (30.0–31.2) in Egypt in women (Figure 5a; and
Supplementary Table 2, available as Supplementary data
at IJE online).
Diabetes prevalence trends
Age-standardized diabetes prevalence increased, from
1980 to 2014, from 3.4% (1.5–6.3) to 8.5% (6.5–10.8) in
men, and from 4.1% (2.0–7.5) to 8.9% (6.9–11.2) in
women. Across regions and in both sexes, age-
standardized diabetes prevalence increased over time along
with the global average (Figure 3b).
Prevalences in northern Africa were higher than the glo-
bal average, whereas those in central, eastern and western
Africa were lower. In southern Africa, compared with the
global average, figures were higher in women but similar
in men. Although regional time trends mirrored the global
pattern in most regions, curves were steeper than the global
average in recent years in northern African men and
women and possibly in southern African women.
Credible intervals around the trend curves for most re-
gions overlapped, suggesting that regional differences,
while possible, were not statistically distinguishable due to
limited data availability and large variability in available
data (Figure 3b). Diabetes prevalence by sex was mostly
similar in eastern, western and southern Africa, but might
have been higher in men than in women in central Africa
and higher in women than in men in northern Africa
(Figure 4). Within countries, age-standardized diabetes
prevalence in 2014 ranged from 4.2% (1.8–7.9) in Burundi
to 16.0% (10.0–23.6) in Egypt for men, and from 4.1%
(1.8–7.7) in Burundi to 19.8% (12.9–28.2) in Egypt for
women (Figure 5b and Supplementary Table 2, available
as Supplementary data at IJE online).
Associations between diabetes and BMI
Across countries, there was a strong positive association
between mean BMI level and diabetes prevalence in 2014
for men and women (correlation coefficients of 0.86 and
0.88, respectively) (Figure 6). This is slightly weaker than
the associations observed in 1980 (0.88 and 0.91, respect-
ively). A moderately strong association between absolute
change in BMI and relative change in diabetes was
observed in women (r¼ 0.76), but the association was
weak in men (r¼ 0.34).
Discussion
Over the past three and a half decades, age-standardized
mean BMI and diabetes prevalence have steadily increased
across African regions, at least as steeply as the global
average. There may have been an acceleration of trends for
women’s BMI in all regions, and for diabetes prevalence in
northern African men and women. Estimates in northern
and southern Africa were mostly higher than global aver-
ages, whereas those in other regions were mostly lower.
This probably reflects different stages of the epidemiolo-
gical transitions and other determinants of high BMI and
Figure 4. Scatterplot of male versus female age-standardized mean body mass index and age-standardized diabetes prevalence by African region in
2014.
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Figure 5. Age-standardized mean body mass index and age-standardized diabetes prevalence by sex and country in Africa in 2014.
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diabetes. Arab countries not only had the highest diabetes
prevalence in Africa, but also have some of the highest
worldwide prevalences,11 explained to some extent by dif-
ferences in diet, physical (in)activity and obesity.10 Mean
BMI was consistently higher in women than in men,
whereas male-female differences in diabetes prevalence
varied across regions.
The fact that average BMI increased steadily over the
same period, as well as evidence of an association between
BMI and diabetes in 2014, affirms the role of adiposity as
a driver of diabetes across Africa. Estimates were, how-
ever, based on limited data sources, particularly in
sub-Saharan Africa (SSA), with nearly 20 SSA countries
having no data for diabetes.
Other investigators have estimated diabetes prevalence
in Africa. Manne-Goehler and colleagues analysed individ-
ual participant data from surveys conducted in mostly 15
to 64-year-olds across 12 SSA countries between 2005 and
2015 (STEPwise approach applied in 11 surveys), and re-
ported a median diabetes prevalence of 5% (range 2% to
14%).12 The International Diabetes Federation (IDF)
Diabetes Atlas,13 using substantially fewer data sources
than ours, estimated the age-standardized diabetes preva-
lence in 20 to 79-year-old adults in 2015 to be 3.8% (95%
Figure 6. Age-standardized diabetes prevalence versus age-standardized mean body mass index in African men and women in 2014, by region and
per capita gross domestic product (GDP).
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confidence intervals 2.1–6.7%) in SSA, and 10.7% (7.4–
14.2%) in the Middle East and North Africa. In a meta-
analysis of prevalence studies, published between 2000
and 2015, of diabetes among older SSA persons, the over-
all prevalence was 13.7% (11.3–16.3%) among 55 year
olds.14 Published studies and ours have used overlapping
data sources, but different time-periods, geographical
coverage, diabetes definitions, population coverage, mod-
elling/estimation strategies and the results are, therefore,
not directly comparable.
Our findings of increasing diabetes prevalence across
Africa between 1980 and 2014 are consistent with succes-
sive IDF estimates.13 However, the IDF does not estimate
trends, relying instead on successive cross-sectional re-
ports, and an earlier trend study focused on FPG.15
Therefore our estimates are the first consistent diabetes
trend estimates for Africa, including by its regions.
Studies in populations of European origin have consist-
ently reported higher diabetes prevalence in men than in
women, with widening gaps as populations undergo the
economic transition from less developed to more affluent
societies.16,17 In the US National Health Interview Surveys,
diabetes prevalence in African-Americans was higher in
women than in men over the years 1963–85. However,
during this same period, diabetes prevalence increased
more steeply in African-American men than women.18 We
found variable patterns of sex differences, with diabetes
prevalence in 2014 being mostly similar or higher in men
at a low prevalence, and higher in women at a high preva-
lence. Several mechanisms, reviewed elsewhere,19 have
been suggested to explain sex differences in diabetes inci-
dence (or the lack thereof) across populations and settings.
Five years after the adoption of the United Nations’ reso-
lution on NCDs,20 and three years after the introduction of
the Global NCD Action Plan,8 good quality nationally rep-
resentative data on the prevalence of such a major NCD are
still lacking in most African countries. Our findings, in con-
sequence, were based on relatively few data points per
country and on the statistical model for many countries.
STEPs surveys are growing data sources for diabetes and
obesity studies in Africa. Their advantages include national
or regional representativeness for some, and the use of
standardized questionnaires and protocols which facilitate
cross-country comparisons. STEPs data, however, have
limitations discussed extensively elsewhere.12 Furthermore,
measurement of biomarkers has not been implemented
across all STEPs surveys in Africa. This is unfortunate be-
cause up to two-thirds of cases remain undiagnosed and are
uncovered only through biomarker measurements. Where
biomarkers have been measured, the WHO recommends
testing fasting venous blood glucose for diabetes.21 There
are concerns that fasting glucose alone may not capture all
cases of undiagnosed diabetes in Africans, whose early
stages of the disease are probably expressed through ele-
vated 2-h post-OGTT glucose. A study in ‘Coloured’ (i.e.
mixed race) South Africans indicated that nearly 50% with
undiagnosed diabetes would be missed in the absence of
OGTT.22
Notwithstanding the challenges of implementing opti-
mal diabetes biomarker measurements in population-based
surveys, the many uncertainties around the true burden of
diabetes invites cross-country efforts to generate reliable
data. This, together with pleas for survey data from Africa
to be more publicly available, to maximize their use for re-
search and policy formulation,12,23 might serve as baseline
support for the introduction of successful diabetes preven-
tion and control efforts.
Other limitations in the interpretation of these study
findings warrant consideration. Regions, as defined in this
study, are general geographical entities comprising coun-
tries with substantial heterogeneities which can affect dia-
betes and BMI estimates. However, each region reflects
existing common entities recognized by the African Union,
and includes some form of concerted action on health.
The current study, however, has major strengths. This is
the first time estimates have been made, from a broad
African perspective, of trends in diabetes and BMI. This
provides an opportunity for detailed cross-regional com-
parisons. Despite the limited number of data sources, esti-
mates in this study are based on a larger amount of
population-based data than previous initiatives.12
A high-level response to the growing diabetes threat in-
cludes the 2007 Strategy for Diabetes Prevention and
Control in Africa,5 the 2009 Mauritius Call for Action,6
and the 2016 Dar es Salaam Call to Action on Diabetes
and other NCDs.7 More generally, all countries adopted
the WHO Global Action Plan for the Prevention and
Control of NCDs 2013–2020.8 Despite the increasing
awareness of the growing diabetes burden, ensuing invest-
ment and actions are not yet commensurate with the mag-
nitude of the challenge.24 Going forward, the Institute of
Medicine has recognized the importance of locally relevant
evidence to successfully contextualize and implement pre-
vention and control lessons from other parts of the
world.25
Africa’s continuing urbanization offers an opportunity
to develop urban environments conducive to healthy
choices which could reduce obesity and diabetes risk.
International Journal of Epidemiology, 2017, Vol. 46, No. 5 1429
Tailoring the MNCH platforms which fight undernutrition
to address healthy eating in general could prevent and con-
trol both under- and overnutrition. Locally relevant solu-
tions are yet to be devised to promote effective diabetes
risk reversal26 in Africa, where weight loss-related HIV/
AIDS stigma is common. However, the platforms created
to address common infectious diseases, such as HIV/AIDS
and tuberculosis, offer excellent opportunities for imple-
menting diabetes risk screening and reduction strategies.27
Integrating prevention and care services for common
chronic infectious and non-infectious diseases in Africa28
could facilitate, for NCD prevention and control, the
transfer of skills, and leverage some of the abundant infec-
tious disease resources.
The current study has refined, for Africa, the previous
global efforts of the NCD Risk Factor Collaboration.10,11
The prevalence of diabetes is substantial and possibly
growing faster than elsewhere, probably triggered by
increasing obesity. This study highlights the urgent need
for locally relevant knowledge, supportive policies, ad-
equately equipped health services and optimal social and
physical environments to address the dual burden of rising
obesity and diabetes.
Supplementary Data
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